https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GlaxoSmithKline-plc-RELVAR-ELLIPTA-receives-European-marketing-authorisation-for-the-treatment-17473509/?utm_source=telegram&utm_medium=social&utm_campaign=share